Lv12
90 积分 2025-10-14 加入
Two decades of pegfilgrastim: what have we learned? Where do we go from here?
23小时前
待确认
Evolving Trends in Surgically Managed Lung Cancer: A 16-Year Hospital-Based Epidemiological Analysis
1个月前
已完结
Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC
2个月前
已完结
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort
2个月前
已完结
Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer
2个月前
已完结
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
3个月前
已完结
Thrombopoietin-Receptor Agonists in Chemotherapy-Induced Thrombocytopenia
3个月前
已完结
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or MetastaticROS1Fusion–Positive Non–Small-Cell Lung Cancer
3个月前
已关闭
A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancer
3个月前
已完结
Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer
4个月前
已完结
皖公网安备34019202002308
